Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03444360

Ligand	Ligand name	Chain	PDB	Tanimoto
FOK	FORSKOLIN	A,C	3C16	0.75
FOK	FORSKOLIN	A,C	1CJU	0.75
FOK	FORSKOLIN	A,C	1TL7	0.75
FOK	FORSKOLIN	A,B	1AB8	0.75
FOK	FORSKOLIN	A,C	3C14	0.75
FOK	FORSKOLIN	A,C	1CJT	0.75
FOK	FORSKOLIN	A,B,C	1CUL	0.75
FOK	FORSKOLIN	A,C	1CJV	0.75
FOK	FORSKOLIN	A,C	3C15	0.75
FOK	FORSKOLIN	A,C	1U0H	0.75
FOK	FORSKOLIN	A,B,C	1CS4	0.75
FOK	FORSKOLIN	A,C	1CJK	0.75
GR3	3-ACETOXY-17-(1-FORMYL-5-METHYL-3-OXO-HEX-4-ENYL)-16-HYDROXY-4,10,13,14-TETRAMETHYL-2,3,4,5,6,9,10,11,12,13,14,15,16,17-TETRADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHRENE-4-CARBOXYLIC ACID	B,D	1AWH	0.78
MRC	MUPIROCIN	A	1JZS	0.71
MRC	MUPIROCIN	A,T	1FFY	0.71
MRC	MUPIROCIN	A	1QU3	0.71
MRC	MUPIROCIN	A,T	1QU2	0.71
0AS	asiatic acid	A	2QN1	0.75
TH2	TESTOSTERONE HEMISUCCINATE	A,B	2CBT	0.73
TH2	TESTOSTERONE HEMISUCCINATE	A,B,C,D,E,F	2CBQ	0.73
TH2	TESTOSTERONE HEMISUCCINATE	A	2CBO	0.73
RGC	REIDISPONGIOLIDE C	A	2ASP	0.75
8PG	(8S,12S)-15S-HYDROXY-9-OXOPROSTA-10Z,13E-DIEN-1-OIC ACID	A,B	2G5W	0.71
PLO	(3BETA)-3-HYDROXYPREGN-5-EN-20-ONE	A	1Q20	0.71
E4H	(3R,4S,5S,7R,9E,11R,12R)-12-ETHYL-4-HYDROXY-3,5,7,11-TETRAMETHYLOXACYCLODODEC-9-ENE-2,8-DIONE	A,B	2HFK	0.8
GR4		H,I	1AWF	0.72
LVA	(3R,5R)-7-((1R,2R,6S,8R,8AS)-2,6-DIMETHYL-8-{[(2R)-2-METHYLBUTANOYL]OXY}-1,2,6,7,8,8A-HEXAHYDRONAPHTHALEN-1-YL)-3,5-DIHYDROXYHEPTANOIC ACID	A,B	1T02	0.92
E7B		A,B	3E7B	0.72
114	COMPACTIN	A,B,C,D	1HW8	0.92
0MA	maslinic acid	A	2QN2	0.75
NTH	SUCCINIC ACID MONO-(13-METHYL-3-OXO-2,3,6,7,8,9,10,11,12,13,14,15,16,17-TETRADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN-17-YL) ESTER	A,B	1BUQ	0.72
GA3	GIBBERELLIN A3	A	2ZSH	0.72
GA3	GIBBERELLIN A3	A,B,C,D,E,F	3ED1	0.72
OVA	3,4-DIHYDROXY-2-METHOXY-4-METHYL-3-[2-METHYL-3-(3-METHYL-BUT-2-ENYL) -OXIRANYL]-CYCLOHEXANONE	A	2GZ5	0.73
OVA	3,4-DIHYDROXY-2-METHOXY-4-METHYL-3-[2-METHYL-3-(3-METHYL-BUT-2-ENYL) -OXIRANYL]-CYCLOHEXANONE	A	1B59	0.73
MVB	(1S,7S,8S,8AR)-1,2,3,7,8,8A-HEXAHYDRO-7-METHYL-8-[2-[(2R,4R)-TETRAHYDRO-4-HY DROXY-6-OXO-2H-PYRAN-2-YL]ETHYL]-1-NAPHTHALENOL	A,B,C	1YA8	0.86
C0R	CORTICOSTERONE	A	2A3I	0.71
C0R	CORTICOSTERONE	A,B	1Y5R	0.71
CBO	CARBENOXOLONE	A,B,C,D	1HDC	0.72
CBO	CARBENOXOLONE	A,B,C,D	2BEL	0.72
20E	(2beta,3beta,5beta,22R)-2,3,14,20,22,25-hexahydroxycholest-7-en-6-one	A,D	2R40	0.7
SIM	SIMVASTATIN	A,B,C,D	1HW9	0.9
5OP	(5E,13E)-11-HYDROXY-9,15-DIOXOPROSTA-5,13-DIEN-1-OIC ACID	A	2ZB4	0.7
5OP	(5E,13E)-11-HYDROXY-9,15-DIOXOPROSTA-5,13-DIEN-1-OIC ACID	A,B	1V3V	0.7
FUA	FUSIDIC ACID	A	1QCA	0.71
FUA	FUSIDIC ACID	A,B,C,D,E,F,G,H,I,J,K,L	1Q23	0.71
FUA	FUSIDIC ACID	A,B	2VUF	0.71
CLL	CHOLESTERYL LINOLEATE	A,B	1CLE	0.74
OLC	(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate	A	3D4S	0.71
803	LOVASTATIN	A,B	1CQP	0.87
P1A	2,3,14,20,22-PENTAHYDROXYCHOLEST-7-EN-6-ONE	A,D	1R1K	0.7
P1A	2,3,14,20,22-PENTAHYDROXYCHOLEST-7-EN-6-ONE	E,U	1Z5X	0.7
P1A	2,3,14,20,22-PENTAHYDROXYCHOLEST-7-EN-6-ONE	E,F,G,H	2NXX	0.7
DL7	(5beta,14beta,17alpha,25R)-3-oxocholest-7-en-26-oic acid	A	3GYU	0.7
2OB	CHOLESTERYL OLEATE	A	2OBD	0.74
HCY	(11alpha,14beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione	A,B	2VDY	0.7
HCY	(11alpha,14beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione	A	2V95	0.7
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A,B	1E3R	0.7
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A	3DHE	0.7
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A	1J99	0.7
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A	1COY	0.7
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A	1Q22	0.7
DEB	6-DEOXYERYTHRONOLIDE B	A	1Z8P	0.74
DEB	6-DEOXYERYTHRONOLIDE B	A	1JIO	0.74
DEB	6-DEOXYERYTHRONOLIDE B	A	1Z8Q	0.74
DEB	6-DEOXYERYTHRONOLIDE B	A	1OXA	0.74
DEB	6-DEOXYERYTHRONOLIDE B	A	1Z8O	0.74
GMM	GLUCOSE MONOMYCOLATE	A	1UQS	0.78
PG2	PROSTAGLANDIN D2	A,B	1RY0	0.72
13T	13-DEOXYTEDANOLIDE	0,1,3,9,A,B,C,H,J,K,L,M,N,O,Q,R,S,T,U,Y,Z	2OTJ	0.73
SIH	PROGESTERONE-11-ALPHA-OL-HEMISUCCINATE	H	1DBM	0.75
CBW	(3BETA,5BETA,14BETA)-3-HYDROXY-11-OXOOLEAN-12-EN-29-OIC ACID	A	2W4Q	0.74